Roth Capital Initiates Juniper Pharmaceuticals With Buy By: Benzinga via Benzinga April 24, 2015 at 09:18 AM EDT Analysts at Roth Capital initiated coverage on Juniper Pharmaceuticals Inc (NASDAQ: JNP) with a Buy rating. The target price for ... Read More >> Related Stocks: Juniper Pharm Inc